Stockert; Elisabeth

Patent Applications and Registrations

Patent applications and USPTO patent grants for Stockert; Elisabeth.The latest application filed is for "methods of treating neoplastic astrocytoma".

Company Profile

1.19.19

Stockert; Elisabeth - Wien AT
Stockert; Elisabeth - Vienna AT
Stockert; Elisabeth - New York NY
Stockert; Elisabeth - NY NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treating Neoplastic Astrocytoma App 20210032366 - Old; Lloyd J. ; et al.	2021-02-04
Methods Of Treating Meningioma App 20180057606 - Old; Lloyd J. ; et al.	2018-03-01
Specific binding proteins and uses thereof Grant 9,562,102 - Old , et al. February 7, 2	2017-02-07
Specific Binding Proteins And Uses Thereof App 20160046726 - Old; Lloyd J. ; et al.	2016-02-18
Specific binding proteins and uses thereof App 20140255410 - Old; Lloyd J. ; et al.	2014-09-11
Specific binding proteins and uses thereof App 20130266573 - Old; Lloyd J. ; et al.	2013-10-10
Specific Binding Proteins And Uses Thereof App 20120183471 - Old; Lloyd J. ; et al.	2012-07-19
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 8,071,717 - Jager , et al. December 6, 2	2011-12-06
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof App 20100278850 - Jager; Dirk ; et al.	2010-11-04
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof Grant 7,795,409 - Jager , et al. September 14, 2	2010-09-14
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 7,622,568 - Jager , et al. November 24, 2	2009-11-24
Specific binding proteins and uses thereof Grant 7,589,180 - Old , et al. September 15, 2	2009-09-15
Specific binding proteins and uses thereof App 20090220510 - Old; Lloyd J. ; et al.	2009-09-03
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof App 20090203123 - Jager; Dirk ; et al.	2009-08-13
Specific Binding Proteins And Uses Thereof App 20090137782 - Old; Lloyd J. ; et al.	2009-05-28
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof App 20080177031 - Jager; Dirk ; et al.	2008-07-24
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof Grant 7,354,992 - Jager , et al. April 8, 2	2008-04-08
Breast cancer antigens Grant 7,335,467 - Scanlan , et al. February 26, 2	2008-02-26
Small cell lung cancer associated antigens and uses therefor Grant 7,314,721 - Gure , et al. January 1, 2	2008-01-01
Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof Grant 7,291,335 - Stockert , et al. November 6, 2	2007-11-06
Isolated nucleic acid molecules associated with colon cancer and methods for diagnosing and treating colon cancer Grant 6,982,316 - Scanlan , et al. January 3, 2	2006-01-03
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof App 20050063981 - Jager, Dirk ; et al.	2005-03-24
Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof Grant 6,830,924 - Chen , et al. December 14, 2	2004-12-14
Colon cancer antigen panel Grant 6,794,501 - Chen , et al. September 21, 2	2004-09-21
Small cell lung cancer associated antigens and uses therefor App 20040126808 - Gure, Ali O. ; et al.	2004-07-01
Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof App 20040126398 - Jager, Dirk ; et al.	2004-07-01
Colon cancer antigen panel App 20030165834 - Chen, Yao-Tseng ; et al.	2003-09-04
Breast cancer antigens App 20030108888 - Scanlan, Matthew J. ; et al.	2003-06-12
Truncated forms of NY-ESO-1 protein Grant 6,525,177 - Stockert , et al. February 25, 2	2003-02-25
Recombinant human anti-Lewis Y antibodies Grant 6,518,415 - Armour , et al. February 11, 2	2003-02-11
Isolated nucleic acid molecules encoding ESO-1 peptides and uses thereof App 20020164665 - Stockert, Elisabeth ; et al.	2002-11-07
Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof App 20020111470 - Chen, Yao-Tseng ; et al.	2002-08-15
Isolated nucleic acid molecules associated with colon, renal, and stomach cancer and methods of using these Grant 6,403,373 - Scanlan , et al. June 11, 2	2002-06-11
Truncated forms of NY-ESO-1 protein App 20020010321 - Chen, Yao-tseng ; et al.	2002-01-24
Recombinant human anti-Lewis Y antibodies Grant 6,310,185 - Wallace , et al. October 30, 2	2001-10-30
Method for determining status of a cancerous condition by determining antibodies to NY-ESO-1 in a patient sample Grant 6,251,603 - Jager , et al. June 26, 2	2001-06-26
Recombinant human anti-Lewis Y antibodies Grant 5,874,060 - Armour , et al. February 23, 1	1999-02-23
Monoclonal antibodies which bind to tumor rejection antigen precursor melan-A, and uses thereof Grant 5,674,749 - Chen , et al. October 7, 1	1997-10-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.